Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose IV Iron + ESA in Chemotherapy Induced Anemia
NCT05768997Phase 3Recruiting
- Sponsor
- Hallym University Medical Center
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose, sponsored by Hallym University Medical Center. Started Mar 2023; status: recruiting.
02
Drugs
ferric derisomaltose
Beyond the preview
Go deeper on NCT05768997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05768997.